Evidence map›Paper›PMID 35429442›Full record

ReviewThe lancet. Gastroenterology & hepatology2022

Investigation and management of Wilson's disease: a practical guide from the British Association for the Study of the Liver.

Samuel Shribman, Thomas Marjot, Abubakar Sharif, Sunitha Vimalesvaran, Aftab Ala, Graeme Alexander, Anil Dhawan, James Dooley, Godfrey T Gillett, Deirdre Kelly and 6 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in The lancet. Gastroenterology & hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. The pathogenesis of liver fibrosis in Wilson's disease: hepatocyte injury and regulation mediated by copper metabolism dysregulation.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. [Gandou Bushen decoction ameliorates ovarian injury in murine hepatolenticular degeneration via the AGE/RAGE/NF-κB signaling pathway].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Removal of Toxic Metabolites-Chelation: Manganese Disorders.Journal of inherited metabolic disease · 2025
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 1 country.

Samuel ShribmanReta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, UK.
Thomas MarjotOxford Liver Unit, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Abubakar SharifLiver Unit, Birmingham Women and Children's Hospital, Birmingham, UK.
Sunitha VimalesvaranPaediatric Liver, GI and Nutrition Centre and Mowat Labs, King's College Hospital, Denmark Hill, London, UK.
Aftab AlaDepartment of Gastroenterology and Hepatology, Royal Surrey NHS Foundation Trust, Guildford; Institute of Liver Studies, King's College Hospital, London, UK.
Graeme AlexanderUniversity College London Institute of Liver and Digestive Health, London, UK.
Anil DhawanPaediatric Liver, GI and Nutrition Centre and Mowat Labs, King's College Hospital, Denmark Hill, London, UK.
James DooleyUniversity College London Institute of Liver and Digestive Health, London, UK.
Godfrey T GillettLaboratory Medicine, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Deirdre KellyLiver Unit, Birmingham Women and Children's Hospital, Birmingham, UK.
Alisdair McNeillSheffield Children's NHS Foundation Trust, Sheffield, UK.
Thomas T WarnerReta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, UK.
Valerie WheaterWilson's Disease Support Group UK, Cambridge, UK.
William GriffithsCambridge Liver Unit, Addenbrooke's Hospital, Cambridge, UK.
Oliver BandmannSheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, UK. Electronic address: o.bandmann@sheffield.ac.uk.
British Association for the Study of the Liver Rare Diseases Special Interest Group
University College London · GBBirmingham Women's Hospital · GBKing's College Hospital · GBAddenbrooke's Hospital · GBNorthern General Hospital · GBRoyal Surrey NHS Foundation Trust · GBSheffield Children's NHS Foundation Trust · GBUniversity of Oxford · GBUniversity of Sheffield · GB

Funding

Medical Research Council MC_EX_MR/N50192X/1Wellcome Trust 102176/B/13/Z
6 · The paper itself

Abstract

Wilson's disease is an autosomal-recessive disorder of copper metabolism with hepatic, neurological, psychiatric, ophthalmological, haematological, renal, and rheumatological manifestations. Making a diagnosis can be challenging given that no single test can confirm or exclude the disease, and diagnostic delays are common. Treatment protocols vary and adverse effects, including paradoxical neurological worsening, can occur. In this Review, we provide a practical guide to the diagnosis of Wilson's disease. We include recommendations on indications for testing, how to interpret results, and when additional investigations are required. We also cover treatment initiation, ideally under the guidance of a specialist centre for Wilson's disease, and the principles behind long-term management. This guidance was developed by a multidisciplinary group of Wilson's disease experts formed through the British Association for the Study of the Liver. The guidance has been endorsed by the British Society of Gastroenterology and approved by the Association of British Neurologists.

Indexed as

Hepatolenticular DegenerationCopperHumansCopper

Identifiers

PMID35429442
OpenAlexW4223914612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.